Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35
United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Eric Venker
1 Oct 2026
Chief Executive Officer
Exercised, kept
92,187
$14.46
$1.33M
Eric Venker
1 Jul 2026
Chief Executive Officer
Exercised, kept
92,188
$14.46
$1.33M
Eric Venker
1 Apr 2026
Chief Executive Officer
Exercised, kept
368,750
$14.46
$5.33M
Showing 250 of 298 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 324
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 10
Sales at will 231
Transactions with no price 0
Shares from compensation/vesting 84,422,925
Sales filed before the plan box existed 33
History held since 15 May 2019